Effect of rituximab or tumour necrosis factor inhibitors on lung infection and survival in rheumatoid arthritis-associated bronchiectasis. (2020)
Attributed to:
MAximizing Sle ThERapeutic PotentiaL by Application of Novel and Stratified approaches (MASTERPLANS)
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1093/rheumatology/kez676
PubMed Identifier: 32065634
Publication URI: http://europepmc.org/abstract/MED/32065634
Type: Journal Article/Review
Volume: 59
Parent Publication: Rheumatology (Oxford, England)
Issue: 10
ISSN: 1462-0324